Kingdon Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Kingdon Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-55,555	Closed	-$5.16M	–	107
2021 Q4	$5.16M	Buy	+55,555	New	+$3.66M	0.59%	47

Kingdon Capital Management's ARNA Position: Q1 2022 in Review

Kingdon Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 55,555 shares — an estimated $5.16M sold.

Kingdon Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $5.16M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Kingdon Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Kingdon Capital Management sold 55,555 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.16M.
Kingdon Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Kingdon Capital Management's Arena Pharmaceuticals Inc position peaked at $5.16M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Kingdon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.